2F8 Uses, Dosage, Side Effects and more
2F8 is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR). 2F8 has been investigated for the treatment of Squamous Cell Cancer and Head and Neck Cancer.
| Attribute | Details |
|---|---|
| Trade Name | 2F8 |
| Generic | Zalutumumab |
| Zalutumumab Other Names | Zalutumumab |
| Type | |
| Formula | C6512H10074N1734O2032S46 |
| Weight | 146641.0546 Da |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
